Glucocorticoid-induced osteoporosis: prevention and treatment

R Ziegler, C Kasperk - Steroids, 1998 - Elsevier
Glucocorticoid excess carries the risk of inducing secondary osteoporosis. In endogenous
Cushing's syndrome, osteoporosis may be the presenting symptom of the underlying …

Glucocorticoid-induced osteoporosis: prevention and treatment.

R Ziegler, C Kasperk - Steroids, 1998 - europepmc.org
Glucocorticoid excess carries the risk of inducing secondary osteoporosis. In endogenous
Cushing's syndrome, osteoporosis may be the presenting symptom of the underlying …

[引用][C] Glucocorticoid-induced osteoporosis: Prevention and treatment

R ZIEGLER, C KASPERK - Steroids, 1998 - pascal-francis.inist.fr
Glucocorticoid-induced osteoporosis : Prevention and treatment CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

[引用][C] Glucocorticoid-induced Osteoporosis: Prevention and Treatment

R Ziegler, C Kasperk - Steroids, 1998 - cir.nii.ac.jp
Glucocorticoid-induced Osteoporosis: Prevention and Treatment | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Glucocorticoid-induced osteoporosis: prevention and treatment

R Ziegler, C Kasperk - Steroids, 1998 - pubmed.ncbi.nlm.nih.gov
Glucocorticoid excess carries the risk of inducing secondary osteoporosis. In endogenous
Cushing's syndrome, osteoporosis may be the presenting symptom of the underlying …

Glucocorticoid-induced Osteoporosis: Prevention and Treatment-a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort

R Ziegler, C Kasperk - Steroids, 1998 - infona.pl
Glucocorticoid excess carries the risk of inducing secondary osteoporosis. In endogenous
Cushing's syndrome, osteoporosis may be the presenting symptom of the underlying …

[引用][C] Glucocorticoid-induced osteoporosis: Prevention and treatment

R ZIEGLER, C KASPERK - Steroids, 1998 - Elsevier